Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Latest News

Concerns Raised Over Behavioral Health Data Exchange Standard

Hearing Loss Myths Debunked
Read More

Some health IT experts are raising concerns about the Data Segmentation for Privacy, or DS4P, standard, which aims to address electronic exchange of behavioral health data, Health Data Management reports.

Background

Behavioral health data are subject to disclosure protections in addition to those required under HIPAA. For example, one federal law — 42 CFR Part 2 — limits federally assisted substance misuse treatment programs’ ability to share behavioral data without patients’ signed consent.

In October, the Office of the National Coordinator for Health IT released the 2015 Edition Health IT Certification Criteria final rule, which includes the DS4P standard.

DS4P aims to address certain barriers in electronic exchange of behavioral health data by applying a set of metadata and encryption to a clinical document, which allows a provider to send behavioral health and substance misuse data to a system with technology that can identify and segregate such data.

Concerns

John Halamka, CIO at Beth Israel Deaconess Medical Center in Boston and co-chair of the Health IT Standards Committee, said DS4P send-and-receive technology is not mature enough to be included in the final rule.

“The Health IT Standards Committee has recommended that no standard ever be included in regulations until it has a level of maturity, adoption and validation in the real world,” Halamka said, adding, “We said, ‘Do not include DS4P because it doesn’t meet any of those criteria.'”

Halamka noted that “the technology doesn’t exist” yet to fully support the policy goals of ONC and the Substance Abuse and Mental Health Services Administration.

In addition, the Health IT Policy Committee’s Privacy and Security Workgroup raised concerns with DS4P, such as:

  • Limitations regarding document-level sequestration;
  • Provider discomfort about electronic health records that are incomplete because patients have withheld certain information;
  • Uncertainty about data entry policies and implications for subsequent disclosure;
  • Uncertainty about DS4P’s ability to comply with 42 CFR Part 2 requirements once a document is received; and
  • Uncertainty about whether DS4P is appropriate for enabling compliance with other data laws that lack redisclosure prohibitions